IMC Chicago’s Clover Health Investments CLOV Stock Holding History

IMC Chicago’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$752K	Sell	427,400 -161,300	-27%	-$350K	﹤0.01%	3577
2025 Q4	$1.38M	Buy	588,700 +99,900	+20%	+$273K	﹤0.01%	2727
2025 Q3	$1.5M	Sell	488,800 -29,200	-6%	-$83.4K	﹤0.01%	2435
2025 Q2	$1.45M	Buy	518,000 +120,400	+30%	+$396K	﹤0.01%	2232
2025 Q1	$1.43M	Sell	397,600 -285,100	-42%	-$1.14M	﹤0.01%	2029
2024 Q4	$2.15M	Buy	682,700 +259,400	+61%	+$927K	﹤0.01%	1819
2024 Q3	$1.19M	Buy	+423,300	New	+$969K	﹤0.01%	1964
2023 Q1	–	Sell	-727,200	Closed	-$676K	–	1291
2022 Q4	$676K	Buy	727,200 +77,300	+12%	+$103K	﹤0.01%	1089
2022 Q3	$1.1M	Buy	649,900 +122,900	+23%	+$322K	﹤0.01%	901
2022 Q2	$1.13M	Sell	527,000 -136,500	-21%	-$363K	﹤0.01%	818
2022 Q1	$2.35M	Buy	663,500 +148,400	+29%	+$430K	﹤0.01%	739
2021 Q4	$1.92M	Sell	515,100 -960,300	-65%	-$5.89M	﹤0.01%	831
2021 Q3	$10.9M	Sell	1,475,400 -68,200	-4%	-$584K	0.01%	477
2021 Q2	$20.6M	Buy	1,543,600 +1,230,800	+393%	+$12.1M	0.03%	320
2021 Q1	$2.37M	Buy	+312,800	New	+$3.53M	﹤0.01%	711

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IMC Chicago's CLOV Position: Q1 2026 in Review

IMC Chicago reduced its Clover Health Investments (CLOV) stake by 23% in Q1 2026, selling an estimated $325K and leaving 492,898 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #3422.

IMC Chicago first reported a position in CLOV in Q2 2021 and has held it in 9 quarters since. The position peaked at $2.63M in Q3 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

IMC Chicago held 492,898 shares of Clover Health Investments worth $868K as of Q1 2026.
IMC Chicago sold 150,066 Clover Health Investments shares in Q1 2026, an estimated $325K.
Clover Health Investments made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3422 holding.
IMC Chicago first reported a position in Clover Health Investments in Q2 2021 and has held it in 9 quarters since.
IMC Chicago's Clover Health Investments position peaked at $2.63M in Q3 2025.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.